Gene therapy for the treatment of mitochondrial DNA disorders

  title={Gene therapy for the treatment of mitochondrial DNA disorders},
  author={Robert W Taylor},
  journal={Expert Opinion on Biological Therapy},
  pages={183 - 194}
  • Robert W Taylor
  • Published 1 February 2005
  • Biology, Medicine
  • Expert Opinion on Biological Therapy
Despite recent epidemiological studies confirming that mitochondrial respiratory chain disorders due to mutations in either the mitochondrial or nuclear genome are amongst the most common inherited human diseases, realistic therapeutic strategies for these patients remain limited. The disappointing response to various vitamins, cofactors and electron acceptors that have been administered to patients in an attempt to bypass the underlying respiratory chain defect, coupled with the complexities… Expand
Experimental Strategies Towards Treating Mitochondrial DNA Disorders
Experimental, genetic-based strategies that have been or are being explored towards developing treatments for mitochondrial disorders are considered, focussing on two specific areas which are actively pursuing—assessing the benefit of exercise training for patients with mtDNA defects, and the prevention of mtDNA disease transmission. Expand
Mitochondrial ATP synthase disorders: molecular mechanisms and the quest for curative therapeutic approaches.
The application of novel scientific approaches promises to deepen the understanding of the molecular mechanisms of the ATP synthase, unravel novel therapeutic pathways and improve the unfortunate situation of the patients suffering from such diseases. Expand
Mitochondrial respiratory chain disorders in childhood: insights into diagnosis and management in the new era of genomic medicine.
A broad overview of the clinical presentations of MRCDs in childhood is provided, evaluating the different diagnostic approaches and treatment options, and highlighting the recent research advances in this area. Expand
mtDNA T8993G mutation‐induced mitochondrial complex V inhibition augments cardiolipin‐dependent alterations in mitochondrial dynamics during oxidative, Ca2+, and lipid insults in NARP cybrids: a potential therapeutic target for melatonin
It is demonstrated for the first time that NARP mutation significantly enhances apoptotic death as a result of three distinct lethal mitochondrial apoptotic insults including oxidative, Ca2+, and lipid stress. Expand
Ciências Mitochondrial genetic therapy in Parkinson ’ s disease Cloning mitochondrial gene ND 1
....................................................................................................... ix IntroductionExpand
[Oedema with acute pseudokeratoconus corneal aspect in a case of Kearns-Sayre syndrome].
The possible physiopathologic mechanisms are debated and the preferred hypothesis was a dysfunction of endothelial cell pumps, but the extremely complex medical management of fragile patients presenting mitochondrial encephalopathy is emphasized. Expand
Relocalisation nucléaire du gène mitochondrial ATP9 chez la levure Saccharomyces cerevisiae
The question of why there is still genes remaining in the mitochondrial genome is asked and a way to answer experimentally is to artificially relocalize those mitochondrial genes to the nucleus. Expand
Œdème avec déformation cornéenne d’aspect pseudo-kératoconique aigu au cours d’un syndrome de Kearns-Sayre
Le role d’une defaillance des pompes endotheliales, fortes consommatrices d”energie, nous semble important dans l’importance de l”hydrops”. Expand


Approaches to mitochondrial gene therapy.
The current state of the development of mitochondria-specific DNA delivery systems is described and some unique hurdles that need to be overcome are outlined if the developed systems is to progress. Expand
Development of Mitochondrial Gene Replacement Therapy
A novel protein transduction technology that allows insertion and expression of the human mitochondrial genome into mitochondria of living cells and delivers mtDNA in vivo is presented, opening the way to rational development of mitochondrial gene replacement therapy of mtDNA-based diseases. Expand
Treatment of Mitochondrial Disease
This review will evaluate the current biochemical strategies available to clinicians for the management of patients with mitochondrial disease and examine the possible approaches to the gene therapy of mitochondrial DNA defects. Expand
Strategies for treating disorders of the mitochondrial genome.
The theory behind several concepts in the progress towards an antigenomc approach to treating mtDNA disorders are presented and progress is reported. Expand
Gene therapy for mitochondrial DNA defects: is it possible?
This review addresses the unique problems associated with the treatment of defects of the mitochondrial genome by gene therapy, and discusses the approaches which the authors believe may be of value. Expand
Mitochondrial disorders.
  • M. Zeviani
  • Medicine
  • Supplements to Clinical neurophysiology
  • 2004
An increasing number of nuclear disease genes have been discovered in association with syndromes caused by oxidative phosphorylation failure and provide both diagnostic tools and new pathogenetic insights in a rapidly expanding area of neurogenetics. Expand
Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria.
It is demonstrated that mitochondria targeted by the SmaI enzyme showed specific elimination of the mutant mtDNA, resulting in restoration of both the normal intracellular ATP level and normal mitochondrial membrane potential. Expand
Gene shifting: a novel therapy for mitochondrial myopathy.
Data show that it is possible to reverse the molecular events that led to expression of metabolic myopathy and demonstrate the effectiveness of this form of 'gene shifting' therapy. Expand
Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options.
A range of current reproductive options that may be considered for prevention of transmission of mtDNA mutations, including the use of donor oocytes, prenatal diagnosis, and preimplantation genetic diagnosis, plus possible future options such as nuclear transfer and cytoplasmic transfer are described. Expand
Mitochondrial Encephalomyopathies: Therapeutic Approach
This review of therapeutic approaches for mitochondrial diseases considers sequentially several different therapeutic approaches, with increasing interest in the administration of reactive oxygen species scavengers both in primary mitochondrial diseases and in neurodegenerative diseases directly or indirectly related to mitochondrial dysfunction. Expand